When there will never be a randomized controlled trial.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26230199.
- Also identified by DOI 10.1038/ki.2015.123 and PMC identifier 5505498.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There are many unanswered questions about how to manage secondary hyperparathyroidism and associated alterations in mineral metabolism in patients with end-stage renal disease. We provide commentary on an observational study by Komaba et al. that presents interesting new insights into the long-standing controversy related to the impact of parathyroidectomy on survival of hemodialysis patients.
Medical subject headings
- Cardiovascular Diseases
- Hyperparathyroidism, Secondary
- Kidney Failure, Chronic
- Parathyroidectomy